Skip to main content
FLYW $18.81 +3.13%
FLYW logo

FLYW · Flywire Corp

Track FLYW — free
$18.81 +0.57 (+3.13%) At close · Aug 14
Market Cap
$2.29B
Shares
121.67M
All earnings calls

Earnings call · FY2025 Q4

Flywire Corp Q4 FY2025 Earnings Call

Flywire Corp Q4 FY2025 Earnings Call

Concluded Feb 24, 2026 Audio replay
Feb 24, 2026 1:01:00 36 turns
Period
FY2025 Q4
Runtime
1:01:00
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Flywire reported strong Q4 and full-year 2025 results with revenue and adjusted EBITDA exceeding expectations, delivering record free cash flow of $62 million in 2025, but guided to a temporary gross margin decline in 2026 due to early-stage ramp economics on new wins like Cleveland Clinic.

Education Vertical 44 Travel Vertical 34 M&A and Sertifi Integration 23 Enterprise Growth Engine and Go-To-Market 22 Profitability and Margin Expansion 21 Platform Embedding and Competitive Moat 19

Management tone

Confident

Net tone +62 · low hedging

Grounding quotes
  • “Before we share more details about an outstanding quarter across all our operating metrics”
  • “an outstanding quarter across all our operating metrics”
  • “we have scaled Flywire into a diversified, resilient, and increasingly profitable business”
  • “This transformation is structural, not cyclical”

Forward guidance

6 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $157.54M +34% YoY
Net income · derived Q4 $33,000

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Adjusted EBITDA margin expanded from nearly 6% to 20% over the last three years
  • Free cash flow scaled from $5 million in 2021 to $62 million in 2025
  • Revenue churn across education and travel was below 1% last year
  • Approximately 90% of education revenue and over 70% of travel revenue comes from enterprise clients generating more than $100K in trailing twelve-month revenue
  • Strong Q1 2026 gross profit dollar growth guidance of 20% to 22%, including 7 points from the Sertifi acquisition

Risks & pressure points

  • Gross profit margin pressure expected in 2026 due to early-stage ramp economics on payment processing programs like Cleveland Clinic and B2B invoiced cross-sell
  • Cleveland Clinic and B2B invoiced cross-sell ramp pressures expected to continue through most of the first half and taper in the second half
  • CEO noted valuation dislocation makes private M&A challenging as private companies still hold high valuations
  • Risks highlighted include U.S. policy changes impacting higher education, foreign student enrollment, immigration, and visa policy

Key moments

Jump directly to management's words in the synchronized transcript.

“Over the past several years, we have meaningfully inflected and scaled free cash flow from $5 million in 2021 to $62 million in 2025.” Michael Massaro, CEO

Forward guidance

From the 8-K filed Feb 24, 2026.

Metric Guided
FX-Neutral Revenue Less Ancillary Services Growth table
Fiscal Year 2026
15% – 21%
Adjusted EBITDA Margin Growth table
Fiscal Year 2026
150% – 350%
FX-Neutral Revenue Less Ancillary Services Growth table
First Quarter 2026
26% – 30%
Adjusted EBITDA Margin Growth table
First Quarter 2026
100% – 350%
FX-Neutral Revenue Less Ancillary Services Growth
Q1 2026
26% – 30%
Adjusted EBITDA Margin Expansion (YoY)
Q1 2026
100% – 350%
Full-screen source Call document